- Home
- CLSK vs BHC Comparison
CLSK vs BHC Comparison
Compare CLSK & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSK
- BHC
- Stock Information
- Founded
- CLSK 1987
- BHC N/A
- Country
- CLSK United States
- BHC Canada
- Employees
- CLSK 270
- BHC N/A
- Industry
- CLSK Finance: Consumer Services
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- CLSK Finance
- BHC Health Care
- Exchange
- CLSK Nasdaq
- BHC Nasdaq
- Market Cap
- CLSK 2.6B
- BHC 2.5B
- IPO Year
- CLSK N/A
- BHC N/A
- Fundamental
- Price
- CLSK $9.82
- BHC $7.49
- Analyst Decision
- CLSK Strong Buy
- BHC Hold
- Analyst Count
- CLSK 9
- BHC 2
- Target Price
- CLSK $20.66
- BHC $9.00
- AVG Volume (30 Days)
- CLSK 19.3M
- BHC 4.6M
- Earning Date
- CLSK 08-07-2025
- BHC 07-30-2025
- Dividend Yield
- CLSK N/A
- BHC N/A
- EPS Growth
- CLSK N/A
- BHC N/A
- EPS
- CLSK 0.98
- BHC 0.27
- Revenue
- CLSK $631,937,000.00
- BHC $9,858,000,000.00
- Revenue This Year
- CLSK $103.35
- BHC $6.28
- Revenue Next Year
- CLSK $41.57
- BHC $3.76
- P/E Ratio
- CLSK $10.01
- BHC $28.24
- Revenue Growth
- CLSK 84.66
- BHC 7.13
- 52 Week Low
- CLSK $6.45
- BHC $4.25
- 52 Week High
- CLSK $17.97
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- CLSK 41.39
- BHC 60.31
- Support Level
- CLSK $8.97
- BHC $7.45
- Resistance Level
- CLSK $10.05
- BHC $8.69
- Average True Range (ATR)
- CLSK 0.63
- BHC 0.43
- MACD
- CLSK -0.09
- BHC 0.09
- Stochastic Oscillator
- CLSK 34.41
- BHC 60.13
About CLSK CleanSpark Inc.
Cleanspark Inc is a bitcoin mining company. Through CleanSpark, Inc., and the Company's wholly owned subsidiaries, the company mines bitcoin. The company entered the bitcoin mining industry through its acquisition of ATL. Bitcoin mining is the sole reportable segment of the company.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.